Guardant Health, Inc. 8-K
Research Summary
AI-generated summary
Guardant Health Reports Q4 and Full-Year 2025 Financial Results
What Happened
- Guardant Health, Inc. announced its financial results for the fiscal quarter and full year ended December 31, 2025 via a press release dated February 19, 2026. The press release is furnished as Exhibit 99.1 to the Current Report on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition).
- The company also included a Cover Page Interactive Data File (Inline XBRL) as Exhibit 104. The filing notes that the furnished press release is not considered “filed” for purposes of Section 18 of the Exchange Act and is not automatically incorporated by reference into other SEC filings except as expressly stated.
Key Details
- Filing date: February 19, 2026 (Form 8‑K).
- Reporting period: quarter and year ended December 31, 2025 (financial results announced).
- Exhibits: 99.1 (press release) and 104 (Inline XBRL cover page data).
- Legal note: information furnished (including Exhibit 99.1) is not deemed “filed” under Section 18 and has limited incorporation-by-reference effect.
Why It Matters
- This 8‑K signals Guardant’s public release of its latest earnings and revenue-related results (quarterly and annual), which investors should review to assess recent business performance and trends.
- Because the press release is furnished rather than filed, it carries different legal treatment under SEC rules; for detailed, audited financial statements and broader disclosure, investors should consult the company’s upcoming periodic reports (e.g., 10‑K) and the full Exhibit 99.1 press release included with this 8‑K.